Thatcher Rhys, Gregory Nicholas, Cheung Wai Yee, Dunseath Gareth J, Parsons Sharon N, Goodwin Mark, Luzio Stephen D
Institute of Biological Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, UK.
Public Health Wales, Tyndall Street, Cardiff, UK.
BMC Prim Care. 2022 Mar 14;23(1):45. doi: 10.1186/s12875-022-01658-2.
The increasing number of cases of prediabetes in the UK is concerning, particularly in Wales where there is no standard programme of support. The aim of the current service evaluation was to examine the effectiveness of brief lifestyle interventions on glucose tolerance in people at risk of developing type 2 diabetes.
In this pragmatic service evaluation clinical data on people deemed at risk of developing type 2 diabetes were evaluated from two GP clusters. Patients (n = 1207) received a single 15 to 30-min, face-to-face, consultation with a health care practitioner. Interventions were assessed by changes in HbA1c and distribution across the HbA1c ranges 12 months following intervention. Statistical significance of reversion to normoglycaemia and development of diabetes were assessed through comparison with expected rates without intervention.
Between baseline and 12-month follow-up HbA1c fell from 43.85 ± 1.57 mmol/mol (6.16 ± 0.14%) to 41.63 ± 3.84 mmol/mol (5.96 ± 0.35%), a decrease of 2.22 mmol/mol (0.20%) (95% CI 2.01 (0.18%), 2.42 (0.22%); p < 0.0001). The proportion of people with normal glucose tolerance at 12 months (0.50 95%CI 0.47, 0.52) was significantly larger than the lower (0.06 (p < 0.0001) and the upper (0.19 (p < 0.0001)) estimates based on no intervention.
Results indicate significant improvement in glucose tolerance across GP clusters. The brief intervention has the potential to offer a robust and effective option to support people at risk of developing type 2 diabetes. Further research in the form of a randomised trial is needed to confirm this and identify those likely to benefit most from this intervention.
英国糖尿病前期病例数量不断增加,令人担忧,尤其是在威尔士,那里没有标准的支持项目。当前服务评估的目的是研究简短生活方式干预对有患2型糖尿病风险人群的糖耐量的有效性。
在这项务实的服务评估中,从两个全科医生群组评估了被认为有患2型糖尿病风险人群的临床数据。患者(n = 1207)接受了与医疗保健从业者进行的一次15至30分钟的面对面咨询。通过干预后12个月糖化血红蛋白(HbA1c)的变化以及HbA1c范围的分布来评估干预措施。通过与无干预情况下的预期发生率进行比较,评估血糖恢复正常和糖尿病发生的统计学显著性。
在基线和12个月随访之间,HbA1c从43.85±1.57 mmol/mol(6.16±0.14%)降至41.63±3.84 mmol/mol(5.96±0.35%),下降了2.22 mmol/mol(0.